Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
S-234462
print preview
bookmark
share with colleague
General Information
Company
Shionogi & Co. Ltd.
Description
Oral neuropeptide Y receptor Y5 (NPY5R) antagonist
Molecular Target
Neuropeptide Y receptor Y5 (NPY5R)
Mechanism of Action
Neuropeptide Y receptor Y5 (NPY5R) antagonist
Latest Stage of Development
Phase I
Indication
Obesity
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy